InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Mates Sharon, Chairman & CEO. Officer active across 1 companies, notably Intra-Cellular Therapies, Inc.. In total, 9 filings have been logged. Total volume traded: €98k. The latest transaction was filed on 9 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€101,43638,925 shares@ €2.605941.0% of flow
Common Stock
SEC:0001209191-22-017858:0·
22,589 shares
Common Stock
SEC:0001209191-22-013346:0·
27,847 shares
Common Stock
SEC:0001209191-22-012385:0·
41,896 shares
Common Stock
SEC:0001209191-22-002984·
41,896 shares
Common Stock
SEC:0001209191-22-002984:0·
€48,8631,416 shares@ €34.50866.9% of flow
Common Stock
SEC:0001209191-21-060741·
€48,8631,416 shares@ €34.50819.7% of flow
Common Stock
SEC:0001209191-21-060741:0·
€24,18110,000 shares@ €2.418133.1% of flow
Common Stock
SEC:0001209191-21-053102·
€24,18110,000 shares@ €2.41819.8% of flow
Common Stock
SEC:0001209191-21-053102:0·
9 of 9 declarations
About Mates Sharon
Sharon Mates is the Chairman, President, and CEO of Intra-Cellular Therapies, Inc. She leads the company in its efforts to develop innovative treatments for psychiatric disorders, focusing on research and development.
